The Global Market for Big Data Technologies and Services is Projected to Reach $60 Billion by 2022

The global market for Optical Imaging is projected to reach US$2.5 billion by 2025, driven by the importance of medical imaging in healthcare in disease prevention, early detection, diagnosis, and treatment. Essential in the management of all virtually all medical conditions and diseases, there is growing interest in R&D of newer and more powerful imaging technologies. Advanced imaging capabilities provide huge benefits such as early detection; better diagnosis; detailed visualization of anatomical structures;  easy and faster physician understanding of disease complications; better clinical decisions; reduced risk of errors; safer in terms of medical radiation exposure; and better patient outcome. Optical medical imaging is the newest imaging technology capable of revolutionizing healthcare in ways hitherto unimagined. Defined as the use of light to visualize cellular and molecular functions in a living body, optical imaging revolves around the use of photons in light to generate images. Light of various wavelengths are used ranging from ultraviolet to near infrared. Fluorescence protein imaging has huge potential in cancer screening given its ability to accurately detect lesions, monitor tumor growth and evaluate patient response to therapy. The technology revolves round the use of endogenous or exogenous materials that illuminate when activated by an external light source. The epidemic spread of cancer bodes well for this technology. In vivo optical imaging using fluorescence and bioluminescence is also invaluable and superior to other methods of imaging. With global cancer burden as measured by new cancer diagnosis poised to reach over 20 million per year by 2020, effective optical methods for cancer imaging will grow in prominence. Read More…